iCELLis® 500+ Bioreactor
The new and improved iCELLis 500+ bioreactor system will simplify large scale cGMP production of virus for vaccines or gene therapy. New features provide enhanced robust control, reliability, and sustainability of high-density adherent cell growth in an automated format.
Boasting a new stainless steel frame and temperature control unit (TCU), the iCELLis 500+ bioreactor is fully compatible with 21 CFR Part 11 standards and cleanroom requirements.
It features an integrated recipe manager, improved tubing management, and a new temperature control unit (TCU), enabling greater process control, faster filling and draining, and further automations of customer processes for cell and gene therapy and vaccines.
Cadence™ Inline Concentrator with Omega™ Polyethersulfone Membranes
Single-pass tangential flow filtration is revolutionizing how tangential flow filtration is implemented in biotech, vaccine, blood plasma and other applications. Pall has now made it even easier to implement this breakthrough patented technology into your process. As with the original Cadence SPTFF modules, the Cadence Inline Concentrator (ILC) is now available with Omega™ polyethersulfone membranes and allows direct flow through in-process volume reduction and can be implemented into a process system or operated as a standalone unit.
This exciting technology leads to economic and practical benefits, including:
- Ability to couple the concentration of product before or after other downstream processing (DSP) steps, consequently optimizing other steps and reducing in-process pool tank volumes
- Continuous processing in DSP
- Easy integration of the assembled module, allowing plug-and-play
- Potential reduction of product damage or aggregation due to reduced residence time and shear exposure